ETF Financing Ranking | GF CSI HK Innovative Drugs Industry ETF(QDII) (513120) had a net financing buy-in of CNY 37.67 million, ranked in the first tier of the entire market-20260723

NewTimeSpace (newtimespace.com) News, Jul 23, 2026, GF CSI HK Innovative Drugs Industry ETF(QDII) (513120.SH) increased by 0.51%, had a turnover of CNY 7.86 billion. Obtained financing buy-in of CNY 670.22 million, and financing repayment of CNY 632.55 million, with a net financing buy-in of CNY 37.67 million, ranked in the first tier of the entire market. (Data source: Wind)

GF CSI HK Innovative Drugs Industry ETF(QDII) (513120.SH), off-exchange connection (A type: 019670; C type: 019671).

NewTimeSpace Disclaimer:All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.